LOL, a biotech play is it? I doubt a smoking cessation device is what the market really wants. An alternative to maintain the smokers lifestyle is what the market screams for and is evidenced by the widespread Ecig acceptance by smokers and nonsmokers alike. Let freedom ring! The way to make money on a biotech is to radar the FDA approvals & trials then buy the momo but @ 1.25 a share there is not going to be the same radical returns as there will be on the penny and sub penny ecig plays.
Start with HPNNs accumulation, macd crossing, and golden cross up ahead and realize the filings indicate no pending splits and non contemplated, The CEO controls the HPNN corp and the acquisition target USAcig and they manufacture their own nicotene cartridges right here in the USA greatly reducing cost and they fit the most popularly imported Ecigs from China.
Six pack starter kits @ 14.95. Refills are equivilant to 1.00 per pack! Private label marketing strategy will allow Hop-On to cast a wide net! http://www.hop-on.com/
No one will want to miss this train pulling out of the station next week!
Market Data 
Markets 
http://www.hop-on.com/ 
AI
